Ying Luo

Insider Reports History

Location
Tokyo, Japan
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Ying Luo
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ying Luo:

Company Role Class Num Shares Value Price $ Report Date Ownership
GYRE THERAPEUTICS, INC. Director Common Stock 2,840,376 $1,334,977 $0.4700 30 Oct 2023 By Spouse
GYRE THERAPEUTICS, INC. Director Stock Option (Right to Buy) 26,000 14 Aug 2024 Direct

Insider Reports Filed by Ying Luo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GYRE GYRE THERAPEUTICS, INC. 14 Aug 2024 1 $0 4 Director 16 Aug 2024, 20:56
GYRE GYRE THERAPEUTICS, INC. 31 Oct 2023 1 $0 4 Director 01 Nov 2023, 06:15
GYRE GYRE THERAPEUTICS, INC. 30 Oct 2023 3 $0 4 Director 22 Nov 2023, 19:55
GYRE CATALYST BIOSCIENCES, INC. 26 Dec 2022 0 $0 3 Director 05 Jan 2023, 15:05